| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.61B | 98.98B | 93.28B | 91.47B | 82.48B | 76.91B |
| Gross Profit | 26.51B | 25.02B | 23.95B | 22.57B | 21.72B | 20.58B |
| EBITDA | 8.97B | 8.75B | 8.47B | 7.73B | 7.03B | 6.44B |
| Net Income | 4.58B | 4.78B | 4.50B | 3.94B | 4.15B | 3.52B |
Balance Sheet | ||||||
| Total Assets | 122.80B | 122.99B | 120.18B | 107.51B | 98.40B | 92.41B |
| Cash, Cash Equivalents and Short-Term Investments | 29.48B | 29.98B | 29.22B | 26.26B | 23.97B | 21.31B |
| Total Debt | 11.65B | 11.59B | 11.52B | 10.07B | 5.95B | 4.48B |
| Total Liabilities | 41.68B | 43.30B | 43.73B | 38.44B | 32.50B | 29.00B |
| Stockholders Equity | 80.34B | 78.92B | 75.72B | 68.41B | 65.29B | 62.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.26B | 2.69B | -1.25B | 1.52B | 979.49M |
| Operating Cash Flow | 0.00 | 6.42B | 8.10B | 5.65B | 5.80B | 4.96B |
| Investing Cash Flow | 0.00 | -5.09B | -5.79B | -6.67B | -3.82B | -3.58B |
| Financing Cash Flow | 0.00 | -1.09B | 391.00M | 3.23B | 583.28M | -988.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥15.77B | 8.02 | ― | 3.89% | -3.00% | -29.83% | |
79 Outperform | ¥60.17B | 11.06 | ― | 2.88% | 3.42% | 13.37% | |
74 Outperform | ¥202.44B | 8.69 | ― | 4.09% | 1.69% | 0.94% | |
74 Outperform | ¥2.54T | 14.14 | ― | 1.11% | 2.35% | 0.43% | |
73 Outperform | ¥190.15B | 9.32 | 4.41% | 3.80% | -1.50% | -32.46% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥324.97B | 36.21 | -4.00% | 3.71% | 0.24% | -234.36% |